Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ITOS - iTeos Therapeutics: My Calculations Suggest Q3 Earnings Will Exceed $10 Per Share

ITOS - iTeos Therapeutics: My Calculations Suggest Q3 Earnings Will Exceed $10 Per Share

iTeos Therapeutics Inc.
  • iTeos Therapeutics had a cash balance of about $26.40 per share as of June 30, 2021.
  • iTeos Therapeutics received a non-refundable upfront payment from GlaxoSmithKline representing revenue of approximately $17.80 per share.
  • The payment is non-refundable and no additional performance is required for this upfront payment.
  • My calculations suggest 3rd quarter 2021 earnings per share at more than $10 for a stock trading at $25.
  • iTeos Therapeutics has a 5+ year runway, “buy” recommendations from all analysts, and favorable business catalysts anticipated before calendar year end.

For further details see:

iTeos Therapeutics: My Calculations Suggest Q3 Earnings Will Exceed $10 Per Share
Stock Information
Company Name: iTeos Therapeutics Inc.
Stock Symbol: ITOS
Market: NASDAQ
Website: iteostherapeutics.com
Menu
ITOS ITOS Quote ITOS Short ITOS News ITOS Articles ITOS Message Board
Get ITOS Alerts

News, Short Squeeze, Breakout and More Instantly...